Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing incidence of chronic disease and blood disorders
3.2.1.2 Growing government support for awareness and approval
3.2.1.3 Increasing fundings accelerated R&D efforts
3.2.1.4 Escalated cell-therapy-based research
3.2.1.5 Growing advancement in cell counting technologies
3.2.2 Industry pitfalls & challenges
3.2.2.1 Limitations of counting techniques
3.2.2.2 High cost of advanced cell counting systems
3.3 Regulatory landscape
3.4 Porter’s analysis
3.4.1 Supplier power
3.4.2 Buyer power
3.4.3 Threat of new entrants
3.4.4 Threat of substitutes
3.4.5 Industry rivalry
3.5 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategic dashboard
Chapter 5 Market Estimates and Forecast, By Product Type, 2018 – 2032 ($ Million)
5.1 Key trends
5.2 Instruments
5.2.1 Hemocytometers
5.2.2 Automated cell counters
5.2.2.1 Fluorescence image-based cell counter
5.2.2.2 Flow cytometer
5.2.2.3 Coulter counter
5.2.3 Hematology analyzers
5.2.3.1 Fully-automated analyzers
5.2.3.2 Semi-automated analyzers
5.2.4 Image cytometry
5.2.5 Other instruments
5.3 Consumables & reagents
Chapter 6 Market Estimates and Forecast, By Application, 2018 – 2032 ($ Million)
6.1 Key trends
6.2 Complete blood count
6.3 Cell-based therapies
6.4 Bioprocessing
6.5 Toxicity
6.6 Other applications
Chapter 7 Market Estimates and Forecast, By End-user, 2018 – 2032 ($ Million)
7.1 Key trends
7.2 Hospitals
7.3 Diagnostic laboratories
7.4 Research institutes
7.5 Pharmaceutical & biotechnology companies
7.6 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Million)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 Agilent Technologies, Inc.
9.3 Beckman Coulter, Inc.
9.4 Bio-Rad Laboratories, Inc.
9.5 Biotek Instruments, Inc.
9.6 ChemoMetec A/S
9.7 DeNovix
9.8 Merck KGaA
9.9 NanoEnTek Inc
9.10 Olympus Corporation
9.11 Sysmex Corporation
9.12 Thermo Fisher Scientific Inc.
